CRISL rated Square Pharma “AAA” in the long-term - Share market analysis of dhaka stock exchange, Bangladesh
Black
White

Send This Page To Friends and Colleagues

You can Enter more than one email separated by (,)
Allowed 100 characters only
28 December, 2017 10:41 AM Source: The Financial Express Bangladesh
1514353059.jpg

Credit Rating Information and Services (CRISL) has informed that the Rating Committee of CRISL has assigned the rating to Square Pharmaceuticals Ltd. as “AAA” in the long term.

The rating company has also rated as “ST-1” in the short-term along with a stable outlook, according to a disclosure posted on the Dhaka bourse website on Wednesday.

The rating company rating the Square Pharma in consideration of its audited financials up to June 30, 2017, unaudited financials up to September 30, 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration, the disclosure said.

Each share of Square Pharmaceuticals, which was listed on the Dhaka Stock Exchange (DSE) in 1995, closed at Tk 298.40 on Tuesday at DSE.

Square Pharma, the second largest market listed company in the Bangladesh’s capital market, disbursed 35 per cent cash and 7.50 per cent stock dividend for the year ended on June 30, 2017.

In 2016, the pharma company paid 40 per cent cash and 10 per cent stock dividend.

The company has also reported consolidated first quarter (Q1) earnings per share (EPS) for July-September, 2017 of Tk 4.39 for as against Tk 3.53 for July-September, 2016.

Consolidated net operating cash flow per share (NOCFPS) was Tk 5.41 for July-September, 2017 as against Tk 5.16 for July-September, 2016.

Consolidated net asset value (NAV) per share was Tk 76.22 as on September 30, 2017 and Tk 71.47 as on June 30, 2017.

The company’s paid-up capital is Tk 7.37 billion and authorised capital is Tk 10 billion.

The sponsor-directors own 34.43 per cent stake in the company, while institutional investors own 10 50 per cent, foreign investors 19.27 per cent and the general public 35.80 per cent as of November 30, 2017, the DSE data shows. 

Add Comment | 0   comment

Readers Comment

Nothing found to display
page number 1

Add Comment

Please login first to comment Click here to login
Advanced Charts
Market Map
Real-Time Market Watch
Order Book Data
Stock Screener
LankaBangla Client Login
CSE iTrading
Trading Game
DSE iTrading

Stocks in Focus


Features for Registered Users

E-mail Alerts
Daily Newsletter
Your Watchlist
Advanced Tools
and
Many more

Will automatically display the last quotes you have visited here.

All Rights Reserved - DUInvest © 2013

Login

Do You have an Account ? , Click here to create a new account

Your Opinion Matters

What do you think about the new Website?